BioRad Laboratories (BIO)
(Delayed Data from NYSE)
$330.01 USD
-14.59 (-4.23%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $329.77 -0.24 (-0.07%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth F Momentum D VGM
Earnings News For BIO
-
Bio-Rad (BIO) Q2 Earnings Surpass Estimates, Guidance Lowered
-
Bio-Rad Laboratories (BIO) Surpasses Q2 Earnings Estimates
-
Bio-Rad: Q2 Earnings Snapshot
-
Bio-Rad: Q2 Earnings Snapshot
-
Bio-Rad Reports Second-Quarter 2024 Financial Results
-
Bio-Rad (BIO) to Report Q2 Earnings: What's in the Cards?
-
Why Is Bio-Rad (BIO) Up 7.8% Since Last Earnings Report?
-
Bio-Rad (BIO) Q1 Earnings Surpass Estimates, Margins Down
-
Bio-Rad: Q1 Earnings Snapshot
-
Bio-Rad Laboratories (BIO) Q1 Earnings Surpass Estimates
-
Bio-Rad: Q1 Earnings Snapshot
-
Bio-Rad Reports First-Quarter 2024 Financial Results
-
Analysts Estimate Bio-Rad Laboratories (BIO) to Report a Decline in Earnings: What to Look Out for
-
Bio-Rad Laboratories (BIO) to Post Q1 Earnings: What Awaits?
-
Bio-Rad (BIO) Q4 Earnings Beat, Revenues Miss, Margins Down
-
Bio-Rad: Q4 Earnings Snapshot
-
Bio-Rad: Q4 Earnings Snapshot
-
Bio-Rad: Q4 Earnings Snapshot
-
Bio-Rad: Q4 Earnings Snapshot
-
Bio-Rad Laboratories (BIO) Surpasses Q4 Earnings Estimates
-
Bio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial Results
-
Bio-Rad Laboratories (BIO) to Post Q4 Earnings: What Awaits?
-
Bio-Rad (BIO) Misses Q3 Earnings Estimates, Cuts 2023 View
-
Bio-Rad Laboratories (BIO) Q3 Earnings and Revenues Miss Estimates
-
Bio-Rad: Q3 Earnings Snapshot